Acrolein- and 4-Aminobiphenyl-DNA adducts in human bladder mucosa and tumor tissue and their mutagenicity in human urothelial cells

Oncotarget

Volumn 5, Issue 11, 2014, Pages 3526-3540

  Lee, Hyun Wook ^a   Wang, Hsiang Tsui ^a   Weng, Mao wen ^a   Hu, Yu ^a   Chen, Wei Sheng ^a   Chou, David ^a   Liu, Yan ^a   Donin, Nicholas ^a   Huang, William C ^a   Lepor, Herbert ^a   Wu, Xue Ru ^a   Wang, Hailin ^b   Beland, Frederick A ^c   Tang, Moon Shong ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RESEARCH CENTER FOR ECO ENVIRONMENTAL SCIENCES   (China)

^c NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

4 aminobiphenyl; Acrolein; Bladder cancer; DNA repair; Mutagenesis

Indexed keywords

4 BIPHENYLAMINE; ACROLEIN; GENOMIC DNA; TOBACCO SMOKE; 4-BIPHENYLAMINE; AMINOBIPHENYL DERIVATIVE; DNA ADDUCT;

ARTICLE; BIOACCUMULATION; BLADDER CANCER; BLADDER CARCINOGENESIS; BLADDER MUCOSA; CANCER SUSCEPTIBILITY; CELL TYPE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DNA ADDUCT; EXCISION REPAIR; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR PATHOLOGY; MUTAGENICITY; PROTEIN DEGRADATION; SPECTROSCOPY; TISSUE LEVEL; UROTHELIUM CELL; BLADDER TUMOR; CELL CULTURE; CHEMICALLY INDUCED; CYTOLOGY; DNA REPAIR; DRUG EFFECTS; GENETICS; METABOLISM; MUTAGENESIS; UROTHELIUM;

ACROLEIN; AMINOBIPHENYL COMPOUNDS; CELLS, CULTURED; DNA ADDUCTS; DNA REPAIR; HUMANS; MUTAGENESIS; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 84903535053     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.1954     Document Type: Article

References (63)

1. Wu XR. Urothelial tumorigenesis: a tale of divergent pathways. Nat Rev Cancer. 2005; 5(9):713-725.
2. Siegel R, Naishadham D and Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013; 63(1):11-30.
3. Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A and Abnet CC. Association between smoking and risk of bladder cancer among men and women. JAMA. 2011; 306(7):737-745.
4. Talaska G, al-Juburi AZ and Kadlubar FF. Smoking related carcinogen-DNA adducts in biopsy samples of human urinary bladder: identification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl as a major adduct. Proc Natl Acad Sci U S A. 1991; 88(12):5350-5354.
5. Talaska G. Aromatic amines and human urinary bladder cancer: exposure sources and epidemiology. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2003; 21(1):29-43.
6. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans., World Health Organization. and International Agency for Research on Cancer. (2004). Tobacco Smoke and Involuntary Smoking.
7. Steineck G, Plato N, Norell SE and Hogstedt C. Urothelial cancer and some industry-related chemicals: an evaluation of the epidemiologic literature. Am J Ind Med. 1990; 17(3):371-391.
8. Vineis P. Epidemiology of cancer from exposure to arylamines. Environ Health Perspect. 1994; 102 Suppl 6:7-10.
9. Schulte PA WE, Boeniger M., and Hills B. Occupational exposure to N-substituted aryl compounds. In: Carcinogenic and Mutagenic Responses to Aromatic Amines and Nitroarenes (King, CM, Romano, LJ and Schuetzle, D, eds), elsevier, New York, Amsterdam, London. 1988:22-35.
10. Feng Z, Hu W, Rom WN, Beland FA and Tang MS. 4-aminobiphenyl is a major etiological agent of human bladder cancer: evidence from its DNA binding spectrum in human p53 gene. Carcinogenesis. 2002; 23(10):1721-1727.
11. Feng Z, Hu W, Rom WN, Beland FA and Tang MS. N-hydroxy-4-aminobiphenyl-DNA binding in human p53 gene: sequence preference and the effect of C5 cytosine methylation. Biochemistry. 2002; 41(20):6414-6421.
12. Cancer IAfro. IARC TP53 Database. Available http://www-p53iarcfr/.
13. Feng Z, Hu W, Hu Y and Tang MS. Acrolein is a major cigarette-related lung cancer agent: Preferential binding at p53 mutational hotspots and inhibition of DNA repair. Proc Natl Acad Sci U S A. 2006; 103(42):15404-15409.
14. Wang HT, Weng MW, Chen WC, Yobin M, Pan J, Chung FL, Wu XR, Rom W and Tang MS. Effect of CpG methylation at different sequence context on acrolein-and BPDE-DNA binding and mutagenesis. Carcinogenesis. 2013; 34(1):220-227.
15. Hoffmann D. HS. Advances in Tobacco carcinogenesis. In Cooper, CS and Grover, PL (eds) Handbook of Experimental Pharmacology Springer-Verlag Berlin Heidelberg. 1990:63-102.
16. Lin D, Lay JO, Jr., Bryant MS, Malaveille C, Friesen M, Bartsch H, Lang NP and Kadlubar FF. Analysis of 4-aminobiphenyl-DNA adducts in human urinary bladder and lung by alkaline hydrolysis and negative ion gas chromatography-mass spectrometry. Environ Health Perspect. 1994; 102 Suppl 6:11-16.
17. Cox PJ. Cyclophosphamide cystitis-identification of acrolein as the causative agent. Biochem Pharmacol. 1979; 28(13):2045-2049.
18. Cohen SM, Garland EM, St John M, Okamura T and Smith RA. Acrolein initiates rat urinary bladder carcinogenesis. Cancer research. 1992; 52(13):3577-3581.
19. Ghilarducci DP and Tjeerdema RS. Fate and effects of acrolein. Rev Environ Contam Toxicol. 1995; 144:95-146.
20. Kehrer JP and Biswal SS. The molecular effects of acrolein. Toxicological Sciences. 2000; 57(1):6-15.
21. Bein K and Leikauf GD. Acrolein-a pulmonary hazard. Mol Nutr Food Res. 2011; 55(9):1342-1360.
22. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans., World Health Organization. and International Agency for Research on Cancer. (1995). Dry Cleaning, Some Chlorinated Solvents and Other Industrial Chemicals.
23. Stevens JF and Maier CS. Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease. Mol Nutr Food Res. 2008; 52(1):7-25.
24. Fujioka K and Shibamoto T. Determination of toxic carbonyl compounds in cigarette smoke. Environ Toxicol. 2006; 21(1):47-54.
25. Wang HT, Zhang S, Hu Y and Tang MS. Mutagenicity and sequence specificity of acrolein-DNA adducts. Chemical research in toxicology. 2009; 22(3):511-517.
26. Wang HT, Hu Y, Tong D, Huang J, Gu L, Wu XR, Chung FL, Li GM and Tang MS. Effect of carcinogenic acrolein on DNA repair and mutagenic susceptibility. The Journal of biological chemistry. 2012; 287(15):12379-12386.
27. Tang M-S. (1996) Mapping and quantification of bulky chemicals induced DNA damage using UvrABC nuclease.
28. Canella KA and Seidman MM. Mutation spectra in supF: approaches to elucidating sequence context effects. Mutation research. 2000; 450(1-2):61-73.
29. Rossi MR, Masters JR, Park S, Todd JH, Garrett SH, Sens MA, Somji S, Nath J and Sens DA. The immortalized UROtsa cell line as a potential cell culture model of human urothelium. Environ Health Perspect. 2001; 109(8):801-808.
30. Denissenko MF, Pao A, Tang M and Pfeifer GP. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science. 1996; 274(5286):430-432.
31. Feng Z, Hu W, Amin S and Tang MS. Mutational spectrum and genotoxicity of the major lipid peroxidation product, trans-4-hydroxy-2-nonenal, induced DNA adducts in nucleotide excision repair-proficient and-deficient human cells. Biochemistry. 2003; 42(25):7848-7854.
32. Hatcher JF and Swaminathan S. Detection of deoxyadenosine-4-aminobiphenyl adduct in DNA of human uroepithelial cells treated with N-hydroxy-4-aminobiphenyl following nuclease P1 enrichment and 32P-postlabeling analysis. Carcinogenesis. 1995; 16(2):295-301.
33. Swaminathan S and Hatcher JF. Identification of new DNA adducts in human bladder epithelia exposed to the proximate metabolite of 4-aminobiphenyl using 32P-postlabeling method. Chem Biol Interact. 2002; 139(2):199-213.
34. Beland FA, Doerge DR, Churchwell MI, Poirier MC, Schoket B and Marques MM. Synthesis, characterization, and quantitation of a 4-aminobiphenyl-DNA adduct standard. Chemical research in toxicology. 1999; 12(1):68-77.
35. Wu XR and Sun TT. Molecular cloning of a 47 kDa tissue-specific and differentiation-dependent urothelial cell surface glycoprotein. J Cell Sci. 1993; 106 (Pt 1):31-43.
36. Tu L, Sun TT and Kreibich G. Specific heterodimer formation is a prerequisite for uroplakins to exit from the endoplasmic reticulum. Mol Biol Cell. 2002; 13(12):4221-4230.
37. Moll R, Wu XR, Lin JH and Sun TT. Uroplakins, specific membrane proteins of urothelial umbrella cells, as histological markers of metastatic transitional cell carcinomas. Am J Pathol. 1995; 147(5):1383-1397.
38. Chung FL, Young R and Hecht SS. Formation of cyclic 1, N2-propanodeoxyguanosine adducts in DNA upon reaction with acrolein or crotonaldehyde. Cancer research. 1984; 44(3):990-995.
39. Chung FL, Pan J, Choudhury S, Roy R, Hu W and Tang MS. Formation of trans-4-hydroxy-2-nonenal-and other enal-derived cyclic DNA adducts from omega-3 and omega-6 polyunsaturated fatty acids and their roles in DNA repair and human p53 gene mutation. Mutation research. 2003; 531(1-2):25-36.
40. Gupta RC. Enhanced sensitivity of 32P-postlabeling analysis of aromatic carcinogen:DNA adducts. Cancer research. 1985; 45(11 Pt 2):5656-5662.
41. Melchior WB, Jr., Marques MM and Beland FA. Mutations induced by aromatic amine DNA adducts in pBR322. Carcinogenesis. 1994; 15(5):889-899.
42. Cai J, Bhatnagar A and Pierce WM, Jr. Protein modification by acrolein: formation and stability of cysteine adducts. Chemical research in toxicology. 2009; 22(4):708-716.
43. Bernardi R, Liebermann DA and Hoffman B. Cdc25A stability is controlled by the ubiquitin-proteasome pathway during cell cycle progression and terminal differentiation. Oncogene. 2000; 19(20):2447-2454.
44. Aberle H, Bauer A, Stappert J, Kispert A and Kemler R. beta-catenin is a target for the ubiquitin-proteasome pathway. The EMBO journal. 1997; 16(13):3797-3804.
45. Pedersen-Bjergaard J, Ersboll J, Hansen VL, Sorensen BL, Christoffersen K, Hou-Jensen K, Nissen NI, Knudsen JB and Hansen MM. Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma. N Engl J Med. 1988; 318(16):1028-1032.
46. Vineis P and Ronco G. Interindividual variation in carcinogen metabolism and bladder cancer risk. Environ Health Perspect. 1992; 98:95-99.
47. Chung FL, Chen HJ and Nath RG. Lipid peroxidation as a potential endogenous source for the formation of exocyclic DNA adducts. Carcinogenesis. 1996; 17(10):2105-2111.
48. Tang MS, Wang HT, Hu Y, Chen WS, Akao M, Feng Z and Hu W. Acrolein induced DNA damage, mutagenicity and effect on DNA repair. Mol Nutr Food Res. 2011; 55(9):1291-1300.
49. Rudra PK and Krokan HE. Acrolein cytotoxicity and glutathione depletion in n-3 fatty acid sensitive-and resistant human tumor cells. Anticancer Res. 1999; 19(1A):461-469.
50. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans., World Health Organization. and International Agency for Research on Cancer. (2012). A Review of Human Carcinogens: Personal Habits and Indoor Combustions.
51. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. (1987). 4-aminobiphenyl. In Overall evaluations of carcinogenicity: an updating of IARC monographs volumes 1 to 42: this publication represents the views and expert opinions of an IARC ad-hoc Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 10-18 March 1987.
52. Kadlubar FF, Dooley KL, Teitel CH, Roberts DW, Benson RW, Butler MA, Bailey JR, Young JF, Skipper PW and Tannenbaum SR. Frequency of urination and its effects on metabolism, pharmacokinetics, blood hemoglobin adduct formation, and liver and urinary bladder DNA adduct levels in beagle dogs given the carcinogen 4-aminobiphenyl. Cancer Research. 1991; 51(16):4371-4377.
53. Badawi AF, Hirvonen A, Bell DA, Lang NP and Kadlubar FF. Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. Cancer research. 1995; 55(22):5230-5237.
54. Mao B, Hingerty BE, Broyde S and Patel DJ. Solution structure of the aminofluorene [AF]-external conformer of the anti-[AF]-C8-dG adduct opposite dC in a DNA duplex. Biochemistry. 1998; 37(1):95-106.
55. Cho BP, Beland FA and Marques MM. NMR structural studies of a 15-mer DNA duplex from a ras protooncogene modified with the carcinogen 2-aminofluorene: conformational heterogeneity. Biochemistry. 1994; 33(6):1373-1384.
56. Shapiro R, Ellis S, Hingerty BE and Broyde S. Major and minor groove conformations of DNA trimers modified on guanine or adenine by 4-aminobiphenyl: adenine adducts favor the minor groove. Chemical research in toxicology. 1995; 8(1):117-127.
57. Cho BP, Beland FA and Marques MM. NMR structural studies of a 15-mer DNA sequence from a ras protooncogene, modified at the first base of codon 61 with the carcinogen 4-aminobiphenyl. Biochemistry. 1992; 31(40):9587-9602.
58. Kawanishi M, Matsuda T, Nakayama A, Takebe H, Matsui S and Yagi T. Molecular analysis of mutations induced by acrolein in human fibroblast cells using supF shuttle vector plasmids. Mutation research. 1998; 417(2-3):65-73.
59. Kanuri M, Minko IG, Nechev LV, Harris TM, Harris CM and Lloyd RS. Error prone translesion synthesis past gamma-hydroxypropano deoxyguanosine, the primary acrolein-derived adduct in mammalian cells. The Journal of biological chemistry. 2002; 277(21):18257-18265.
60. Sanchez AM, Minko IG, Kurtz AJ, Kanuri M, Moriya M and Lloyd RS. Comparative evaluation of the bioreactivity and mutagenic spectra of acrolein-derived alpha-HOPdG and gamma-HOPdG regioisomeric deoxyguanosine adducts. Chemical research in toxicology. 2003; 16(8):1019-1028.
61. Minko IG, Washington MT, Kanuri M, Prakash L, Prakash S and Lloyd RS. Translesion synthesis past acrolein-derived DNA adduct, gamma-hydroxypropanodeoxyguanosine, by yeast and human DNA polymerase eta. The Journal of biological chemistry. 2003; 278(2):784-790.
62. Kim SI, Pfeifer GP and Besaratinia A. Lack of mutagenicity of acrolein-induced DNA adducts in mouse and human cells. Cancer research. 2007; 67(24):11640-11647.
63. Yang IY, Hossain M, Miller H, Khullar S, Johnson F, Grollman A and Moriya M. Responses to the major acrolein-derived deoxyguanosine adduct in Escherichia coli. The Journal of biological chemistry. 2001; 276(12):9071-9076.